Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ascorbic acid metabolism and polyol pathway in diabetes.

D K Yue1, S McLennan, E Fisher

  • 1Department of Medicine, University of Sydney, New South Wales, Australia.

Diabetes
|February 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of Complete Inversion of the Uterus.

Illinois medical and surgical journal·2023
Same author

The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons.

Translational psychiatry·2022
Same author

Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.

AJNR. American journal of neuroradiology·2020
Same author

Young-onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Lactobacillus spp. impair the ability of Listeria monocytogenes FBUNT to adhere to and invade Caco-2 cells.

Biotechnology letters·2018
Same journal

Females Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice.

Diabetes·2026
Same journal

Ketone Bodies Derived From Medium-Chain Triglycerides Support Brain Metabolism and Function Under Hypoglycemia in Type 1 Diabetes Mellitus.

Diabetes·2026
Same journal

Targeting the ADA/ADO Axis Rescues β-Cell Failure in Type 2 Diabetes.

Diabetes·2026
Same journal

TXNIP Is Positioned as a Key Mediator of Hyperglycemia-Induced Vascular Senescence.

Diabetes·2026
Same journal

Sex Differences in ER Stress Pathways Are a Key Determinant of β-Cell Proliferation and Resilience.

Diabetes·2026
Same journal

The Mechanism of TNF-α Combined With High Glucose in Regulating Calnexin Aggravates Endoplasmic Reticulum Stress in Endothelial Cell Injury of Diabetic Retinopathy.

Diabetes·2026
See all related articles

Diabetic rats show impaired ascorbic acid (AA) metabolism, with low plasma levels and high urinary excretion. Treatments targeting the polyol pathway, like tolrestat or myo-inositol, normalized these AA levels.

Area of Science:

  • Biochemistry
  • Endocrinology
  • Metabolic Research

Background:

  • Plasma ascorbic acid (AA) is reduced in diabetic rats.
  • Aldose reductase inhibitors (ARIs) like tolrestat can normalize AA levels.
  • The polyol pathway's role in AA metabolism in diabetes requires further investigation.

Purpose of the Study:

  • To investigate the relationship between the polyol pathway and ascorbic acid (AA) metabolism in diabetic rats.
  • To assess the impact of tolrestat and myo-inositol on AA levels and excretion in diabetic models.
  • To explore the potential role of AA metabolic abnormalities in diabetic complications.

Main Methods:

  • Induction of diabetes in rats using streptozocin.
  • Administration of tolrestat (an aldose reductase inhibitor) and myo-inositol.

Related Experiment Videos

  • Measurement of plasma and urinary ascorbic acid (AA) concentrations.
  • Comparison with galactose-fed rat models.

    • Main Results:

    • Diabetes caused a disturbance in AA metabolism within 1 week, characterized by low plasma AA and increased urinary excretion.
    • Both tolrestat and myo-inositol treatments normalized plasma AA levels and reversed increased urinary AA excretion in diabetic rats.
    • Ascorbic acid supplementation normalized plasma AA but further increased urinary AA excretion.
    • Galactose-fed rats exhibited less severe AA metabolic abnormalities compared to diabetic rats.

    Conclusions:

    • Experimental diabetes significantly disrupts the regulation of plasma and urinary ascorbic acid (AA) concentration.
    • A clear relationship exists between the polyol pathway and AA metabolism, with interventions affecting the polyol pathway impacting AA levels.
    • Abnormalities in AA metabolism may contribute to diabetic complications, suggesting aldose reductase inhibitors as a potential therapeutic target.